Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Competent and willing to voluntarily provide informed consent~* 18 years of age or older~* In good general health needing to undergo cataract extraction with lens replacement surgery in one eye, under topical anesthesia~* Other inclusion criteria to be evaluated by the investigator~Exclusion Criteria:~* No allergies to the medications and/or the active ingredients of any of the study medications~* No medications with the same activities as the of the active ingredients in OMS302 for defined time intervals prior to and after surgery~* No other significant eye injuries, eye conditions or general medical conditions likely to interfere with the evaluation of the study medication~* Other exclusion criteria to be evaluated by the investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- OMS302 Solution (Type: EXPERIMENTAL): OMS302 Solution
- OMS302 Mydriatic Solution (Type: EXPERIMENTAL): OMS302 Mydriatic Solution
- OMS302 Anti-inflammatory Solution (Type: EXPERIMENTAL): OMS302 Anti-inflammatory Solution
- Balanced Salt Solution (BSS) Solution (Type: PLACEBO_COMPARATOR): Balanced Salt Solution (BSS) Solution

Based on this trial design, predict the completion outcome and termination type (if applicable).